Updated Jul 16, 2026 · Last SEC filing 2026-07-02
Q32 Bio Inc. (QTTB) has filed 11 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-02. 7 Form 8-K material event filings were reported by QTTB in the last 90 days. InsiderAlpha tracks every QTTB SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001661998 |
|---|
| Form 4 filings (90d) | 11 |
|---|---|
| Form 8-K filings (90d) | 7 |
| Latest Form 4 filing | 2026-07-02 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Manke Isaac | Insider | M — Option exercise | 53.5K | $2.80 | $150K | SEC | |
| ORBIMED ADVISORS LLC | Director | P — Open-market purchase | 1.25M | $8.00 | $10.00M | SEC | |
| Xu Diyong | Director | P — Open-market purchase | 625.0K | $8.00 | $5.00M | SEC | |
| Xu Diyong | Director | P — Open-market purchase | 1.25M | $8.00 | $10.00M | SEC | |
| ORBIMED ADVISORS LLC | Director | P — Open-market purchase | 625.0K | $8.00 | $5.00M | SEC | |
| Morrison Jodie Pope | CEO | S — Open-market sale | 9.9K | $4.51 | $45K | SEC | |
| Kalowski Lee | CFO and President | S — Open-market sale | 4.0K | $4.51 | $18K | SEC | |
| Violette Shelia M. | Chief Scientific Officer | S — Open-market sale | 2.8K | $4.51 | $13K | SEC | |
| Kalowski Lee | CFO and President | A — Grant or award | 53.2K | $0.00 | — | SEC | |
| Violette Shelia M. | Chief Scientific Officer | A — Grant or award | 37.5K | $0.00 | — | SEC | |
| Morrison Jodie Pope | CEO | A — Grant or award | 132.0K | $0.00 | — | SEC | |
| Morrison Jodie Pope | CEO | S — Open-market sale | 22.5K | $3.46 | $78K | SEC | |
| Kalowski Lee | CFO and President | S — Open-market sale | 9.1K | $3.46 | $31K | SEC | |
| Violette Shelia M. | Chief Scientific Officer | S — Open-market sale | 3.0K | $1.80 | $5K | SEC | |
| Morrison Jodie Pope | CEO | S — Open-market sale | 10.5K | $1.80 | $19K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Q32 Bio Inc. (QTTB). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Xu Diyong | 3 | $15.00M |
| Manke Isaac | 3 | $150K |
| ORBIMED ADVISORS LLC | 2 | $15.00M |
| Lundberg Sven Ante | 1 | — |
| GRAYZEL DAVID S. | 1 | — |
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in QTTB insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live QTTB dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.